Joseph R. Nevins - Publications

Affiliations: 
Molecular Genetics and Microbiology Duke University, Durham, NC 
Area:
Genetics, Systematic Biology

168 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Leung JY, Nevins JR. E2F6 associates with BRG1 in transcriptional regulation. Plos One. 7: e47967. PMID 23082233 DOI: 10.1371/journal.pone.0047967  0.64
2012 Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, ... ... Nevins JR, et al. Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587. Jama. 307: 453. PMID 22228686 DOI: 10.1001/jama.2012.2  0.64
2012 Leung JY, Andrechek ER, Cardiff RD, Nevins JR. Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence. Oncogene. 31: 2545-54. PMID 21996730 DOI: 10.1038/onc.2011.433  0.64
2012 Dressman HK, Berchuck A, Chan G, Zhai J, Bild A, Sayer R, Cragun J, Clarke J, Whitaker RS, Li L, Gray J, Marks J, Ginsburg GS, Potti A, West M, ... Nevins JR, et al. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer (Journal of Clinical Oncology (2007) 25 (517-525)) Journal of Clinical Oncology. 30: 678. DOI: 10.1200/JCO.2012.42.0331  0.64
2011 Chang JT, Gatza ML, Lucas JE, Barry WT, Vaughn P, Nevins JR. SIGNATURE: a workbench for gene expression signature analysis. Bmc Bioinformatics. 12: 443. PMID 22078435 DOI: 10.1186/1471-2105-12-443  0.64
2011 Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, Sud S, Barry W, Diehl AM, Provenzale D, Ginsburg GS, Ghadimi BM, Ried T, Nevins JR, Mukherjee S, Hsu D, et al. Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proceedings of the National Academy of Sciences of the United States of America. 108: 17569. PMID 21969600 DOI: 10.1073/pnas.1115170108  0.64
2011 LaBreche HG, Meadows SK, Nevins JR, Chute JP. Peripheral blood signatures of lead exposure. Plos One. 6: e23043. PMID 21829687 DOI: 10.1371/journal.pone.0023043  0.64
2011 LaBreche HG, Nevins JR, Huang E. Integrating factor analysis and a transgenic mouse model to reveal a peripheral blood predictor of breast tumors. Bmc Medical Genomics. 4: 61. PMID 21781289 DOI: 10.1186/1755-8794-4-61  0.64
2011 Freedman JA, Augustine CK, Selim AM, Holshausen KC, Wei Z, Tsamis KA, Hsu DS, Dressman HK, Barry WT, Tyler DS, Nevins JR. A methodology for utilization of predictive genomic signatures in FFPE samples. Bmc Medical Genomics. 4: 58. PMID 21745407 DOI: 10.1186/1755-8794-4-58  0.64
2011 Freedman JA, Tyler DS, Nevins JR, Augustine CK. Use of gene expression and pathway signatures to characterize the complexity of human melanoma. The American Journal of Pathology. 178: 2513-22. PMID 21641377 DOI: 10.1016/j.ajpath.2011.02.037  0.64
2011 Yao G, Tan C, West M, Nevins JR, You L. Origin of bistability underlying mammalian cell cycle entry. Molecular Systems Biology. 7: 485. PMID 21525871 DOI: 10.1038/msb.2011.19  0.64
2011 Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, Kratzke R, Watson MA, Kelley M, Ginsburg GS, West M, Harpole DH, Nevins JR. Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80. The New England Journal of Medicine. 364: 1176. PMID 21366430 DOI: 10.1056/NEJMc1101915  0.64
2011 Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, Petit T, Rouanet P, Jassem J, Blot E, Becette V, Farmer P, André S, Acharya CR, Mukherjee S, ... ... Nevins JR, et al. Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. The Lancet. Oncology. 12: 116. PMID 21277543 DOI: 10.1016/S1470-2045(11)70011-0  0.64
2011 Shats I, Gatza ML, Chang JT, Mori S, Wang J, Rich J, Nevins JR. Using a stem cell-based signature to guide therapeutic selection in cancer. Cancer Research. 71: 1772-80. PMID 21169407 DOI: 10.1158/0008-5472.CAN-10-1735  0.64
2011 Bild AH, Parker JS, Gustafson AM, Acharya CR, Hoadley KA, Anders C, Marcom PK, Carey LA, Potti A, Nevins JR, Perou CM. Correction: An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer Breast Cancer Research. 13. DOI: 10.1186/bcr2909  0.64
2010 Lee TJ, Yao G, Bennett DC, Nevins JR, You L. Stochastic E2F activation and reconciliation of phenomenological cell-cycle models. Plos Biology. 8. PMID 20877711 DOI: 10.1371/journal.pbio.1000488  0.64
2010 Meadows SK, Dressman HK, Daher P, Himburg H, Russell JL, Doan P, Chao NJ, Lucas J, Nevins JR, Chute JP. Diagnosis of partial body radiation exposure in mice using peripheral blood gene expression profiles. Plos One. 5: e11535. PMID 20634956 DOI: 10.1371/journal.pone.0011535  0.64
2010 Barry WT, Kernagis DN, Dressman HK, Griffis RJ, Hunter JD, Olson JA, Marks JR, Ginsburg GS, Marcom PK, Nevins JR, Geradts J, Datto MB. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2198-206. PMID 20368555 DOI: 10.1200/JCO.2009.26.7245  0.64
2010 Gatza ML, Lucas JE, Barry WT, Kim JW, Wang Q, Crawford MD, Datto MB, Kelley M, Mathey-Prevot B, Potti A, Nevins JR. A pathway-based classification of human breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 107: 6994-9. PMID 20335537 DOI: 10.1073/pnas.0912708107  0.64
2010 Wade HE, Kobayashi S, Eaton ML, Jansen MS, Lobenhofer EK, Lupien M, Geistlinger TR, Zhu W, Nevins JR, Brown M, Otteson DC, McDonnell DP. Multimodal regulation of E2F1 gene expression by progestins. Molecular and Cellular Biology. 30: 1866-77. PMID 20123965 DOI: 10.1128/MCB.01060-09  0.64
2009 Friedman DR, Weinberg JB, Barry WT, Goodman BK, Volkheimer AD, Bond KM, Chen Y, Jiang N, Moore JO, Gockerman JP, Diehl LF, Decastro CM, Potti A, Nevins JR. A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6947-55. PMID 19861443 DOI: 10.1158/1078-0432.CCR-09-1132  0.64
2009 Andrechek ER, Cardiff RD, Chang JT, Gatza ML, Acharya CR, Potti A, Nevins JR. Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential. Proceedings of the National Academy of Sciences of the United States of America. 106: 16387-92. PMID 19805309 DOI: 10.1073/pnas.0901250106  0.64
2009 Rempel RE, Mori S, Gasparetto M, Glozak MA, Andrechek ER, Adler SB, Laakso NM, Lagoo AS, Storms R, Smith C, Nevins JR. A role for E2F activities in determining the fate of Myc-induced lymphomagenesis. Plos Genetics. 5: e1000640. PMID 19749980 DOI: 10.1371/journal.pgen.1000640  0.64
2009 Mori S, Chang JT, Andrechek ER, Potti A, Nevins JR. Utilization of genomic signatures to identify phenotype-specific drugs. Plos One. 4: e6772. PMID 19714244 DOI: 10.1371/journal.pone.0006772  0.64
2009 Bild AH, Parker JS, Gustafson AM, Acharya CR, Hoadley KA, Anders C, Marcom PK, Carey LA, Potti A, Nevins JR, Perou CM. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer. Breast Cancer Research : Bcr. 11: R55. PMID 19638211 DOI: 10.1186/bcr2344  0.64
2009 Freedman JA, Chang JT, Jakoi L, Nevins JR. A combinatorial mechanism for determining the specificity of E2F activation and repression. Oncogene. 28: 2873-81. PMID 19543322 DOI: 10.1038/onc.2009.153  0.64
2009 Mori S, Chang JT, Andrechek ER, Matsumura N, Baba T, Yao G, Kim JW, Gatza M, Murphy S, Nevins JR. Anchorage-independent cell growth signature identifies tumors with metastatic potential Oncogene. 28: 2796-2805. PMID 19483725 DOI: 10.1038/onc.2009.139  0.64
2009 Chang JT, Carvalho C, Mori S, Bild AH, Gatza ML, Wang Q, Lucas JE, Potti A, Febbo PG, West M, Nevins JR. A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Molecular Cell. 34: 104-14. PMID 19362539 DOI: 10.1016/j.molcel.2009.02.030  0.64
2009 Hsu DS, Acharya CR, Balakumaran BS, Riedel RF, Kim MK, Stevenson M, Tuchman S, Mukherjee S, Barry W, Dressman HK, Nevins JR, Powers S, Mu D, Potti A. Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 106: 5312-7. PMID 19279207 DOI: 10.1073/pnas.0900827106  0.64
2009 Tebbit CL, Zhai J, Untch BR, Ellis MJ, Dressman HK, Bentley RC, Baker JA, Marcom PK, Nevins JR, Marks JR, Olson JA. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care. Breast Cancer Research and Treatment. 118: 635-43. PMID 19224362 DOI: 10.1007/s10549-008-0301-1  0.64
2009 Augustine CK, Yoo JS, Potti A, Yoshimoto Y, Zipfel PA, Friedman HS, Nevins JR, Ali-Osman F, Tyler DS. Genomic and molecular profiling predicts response to temozolomide in melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 502-10. PMID 19147755 DOI: 10.1158/1078-0432.CCR-08-1916  0.64
2009 Augustine CK, Yoo JS, Potti A, Yoshimoto Y, Zipfel PA, Friedman HS, Nevins JR, Ali-Osman F, Tyler DS. Correction: Article on genomic and molecular profiling to predict response to temozolomide (Clinical Cancer Research (2009) 15, (502-510)) Clinical Cancer Research. 15: 3240. DOI: 10.1158/1078-0432.CCR-15-9-COR  0.64
2008 Carvalho CM, Chang J, Lucas JE, Nevins JR, Wang Q, West M. High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics. Journal of the American Statistical Association. 103: 1438-1456. PMID 21218139 DOI: 10.1198/016214508000000869  0.64
2008 Chen JL, Lucas JE, Schroeder T, Mori S, Wu J, Nevins J, Dewhirst M, West M, Chi JT. The genomic analysis of lactic acidosis and acidosis response in human cancers. Plos Genetics. 4: e1000293. PMID 19057672 DOI: 10.1371/journal.pgen.1000293  0.64
2008 Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, Sud S, Barry W, Diehl AM, Provenzale D, Ginsburg GS, Ghadimi BM, Ried T, Nevins JR, Mukherjee S, Hsu D, et al. A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proceedings of the National Academy of Sciences of the United States of America. 105: 19432-7. PMID 19050079 DOI: 10.1073/pnas.0806674105  0.64
2008 Mori S, Rempel RE, Chang JT, Yao G, Lagoo AS, Potti A, Bild A, Nevins JR. Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma. Cancer Research. 68: 8525-34. PMID 18922927 DOI: 10.1158/0008-5472.CAN-08-1329  0.64
2008 Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3324-30. PMID 18612148 DOI: 10.1200/JCO.2007.14.2471  0.64
2008 Andrechek ER, Mori S, Rempel RE, Chang JT, Nevins JR. Patterns of cell signaling pathway activation that characterize mammary development. Development (Cambridge, England). 135: 2403-13. PMID 18550711 DOI: 10.1242/dev.019018  0.64
2008 Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, ... ... Nevins JR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. Jama. 299: 1574-87. PMID 18387932 DOI: 10.1001/jama.299.13.1574  0.64
2008 Meadows SK, Dressman HK, Muramoto GG, Himburg H, Salter A, Wei Z, Ginsburg GS, Ginsburg G, Chao NJ, Nevins JR, Chute JP. Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. Plos One. 3: e1912. PMID 18382685 DOI: 10.1371/journal.pone.0001912  0.36
2008 Salter KH, Acharya CR, Walters KS, Redman R, Anguiano A, Garman KS, Anders CK, Mukherjee S, Dressman HK, Barry WT, Marcom KP, Olson J, Nevins JR, Potti A. An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. Plos One. 3: e1908. PMID 18382681 DOI: 10.1371/journal.pone.0001908  0.64
2008 Xu M, Kao MC, Nunez-Iglesias J, Nevins JR, West M, Zhou XJ. An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer. Bmc Genomics. 9: S12. PMID 18366601 DOI: 10.1186/1471-2164-9-S1-S12  0.64
2008 Leung JY, Ehmann GL, Giangrande PH, Nevins JR. A role for Myc in facilitating transcription activation by E2F1. Oncogene. 27: 4172-9. PMID 18345030 DOI: 10.1038/onc.2008.55  0.64
2008 Anders CK, Acharya CR, Hsu DS, Broadwater G, Garman K, Foekens JA, Zhang Y, Wang Y, Marcom K, Marks JR, Mukherjee S, Nevins JR, Blackwell KL, Potti A. Age-specific differences in oncogenic pathway deregulation seen in human breast tumors. Plos One. 3: e1373. PMID 18167534 DOI: 10.1371/journal.pone.0001373  0.64
2007 Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, Petit T, Rouanet P, Jassem J, Blot E, Becette V, Farmer P, André S, Acharya CR, Mukherjee S, ... ... Nevins JR, et al. Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. The Lancet. Oncology. 8: 1071-8. PMID 18024211 DOI: 10.1016/S1470-2045(07)70345-5  0.64
2007 Huang W, Nevins JR, Ohler U. Phylogenetic simulation of promoter evolution: estimation and modeling of binding site turnover events and assessment of their impact on alignment tools. Genome Biology. 8: R225. PMID 17956628 DOI: 10.1186/gb-2007-8-10-r225  0.64
2007 Hsu DS, Balakumaran BS, Acharya CR, Vlahovic V, Walters KS, Garman K, Anders C, Riedel RF, Lancaster J, Harpole D, Dressman HK, Nevins JR, Febbo PG, Potti A. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4350-7. PMID 17906199 DOI: 10.1200/JCO.2007.11.0593  0.64
2007 Giangrande PH, Zhang J, Tanner A, Eckhart AD, Rempel RE, Andrechek ER, Layzer JM, Keys JR, Hagen PO, Nevins JR, Koch WJ, Sullenger BA. Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia. Proceedings of the National Academy of Sciences of the United States of America. 104: 12988-93. PMID 17652516 DOI: 10.1073/pnas.0704754104  0.64
2007 Dressman HK, Muramoto GG, Chao NJ, Meadows S, Marshall D, Ginsburg GS, Nevins JR, Chute JP. Gene expression signatures that predict radiation exposure in mice and humans. Plos Medicine. 4: e106. PMID 17407386 DOI: 10.1371/journal.pmed.0040106  0.36
2007 Dressman HK, Berchuck A, Chan G, Zhai J, Bild A, Sayer R, Cragun J, Clarke J, Whitaker RS, Li L, Gray J, Marks J, Ginsburg GS, Potti A, West M, ... Nevins JR, et al. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 517-25. PMID 17290060 DOI: 10.1200/JCO.2006.06.3743  0.64
2007 Kong LJ, Chang JT, Bild AH, Nevins JR. Compensation and specificity of function within the E2F family. Oncogene. 26: 321-7. PMID 16909124 DOI: 10.1038/sj.onc.1209817  0.64
2006 Lancaster JM, Dressman HK, Clarke JP, Sayer RA, Martino MA, Cragun JM, Henriott AH, Gray J, Sutphen R, Elahi A, Whitaker RS, West M, Marks JR, Nevins JR, Berchuck A. Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 16: 1733-45. PMID 17009964 DOI: 10.1111/j.1525-1438.2006.00660.x  0.64
2006 Cheng SH, Horng CF, West M, Huang E, Pittman J, Tsou MH, Dressman H, Chen CM, Tsai SY, Jian JJ, Liu MC, Nevins JR, Huang AT. Genomic prediction of locoregional recurrence after mastectomy in breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 4594-602. PMID 17008701 DOI: 10.1200/JCO.2005.02.5676  0.64
2006 Chang JT, Nevins JR. GATHER: a systems approach to interpreting genomic signatures. Bioinformatics (Oxford, England). 22: 2926-33. PMID 17000751 DOI: 10.1093/bioinformatics/btl483  0.64
2006 Bild AH, Potti A, Nevins JR. Linking oncogenic pathways with therapeutic opportunities. Nature Reviews. Cancer. 6: 735-41. PMID 16915294 DOI: 10.1038/nrc1976  0.64
2006 Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, Kratzke R, Watson MA, Kelley M, Ginsburg GS, West M, Harpole DH, Nevins JR. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. The New England Journal of Medicine. 355: 570-80. PMID 16899777 DOI: 10.1056/NEJMoa060467  0.64
2006 West M, Ginsburg GS, Huang AT, Nevins JR. Embracing the complexity of genomic data for personalized medicine. Genome Research. 16: 559-66. PMID 16651662 DOI: 10.1101/gr.3851306  0.64
2006 Kong LJ, Meloni AR, Nevins JR. The Rb-related p130 protein controls telomere lengthening through an interaction with a Rad50-interacting protein, RINT-1. Molecular Cell. 22: 63-71. PMID 16600870 DOI: 10.1016/j.molcel.2006.02.016  0.64
2006 Dressman HK, Hans C, Bild A, Olson JA, Rosen E, Marcom PK, Liotcheva VB, Jones EL, Vujaskovic Z, Marks J, Dewhirst MW, West M, Nevins JR, Blackwell K. Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 819-26. PMID 16467094 DOI: 10.1158/1078-0432.CCR-05-1447  0.64
2006 Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA, Marks JR, Dressman HK, West M, Nevins JR. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 439: 353-7. PMID 16273092 DOI: 10.1038/nature04296  0.64
2005 Karra R, Vemullapalli S, Dong C, Herderick EE, Song X, Slosek K, Nevins JR, West M, Goldschmidt-Clermont PJ, Seo D. Molecular evidence for arterial repair in atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 102: 16789-94. PMID 16275914 DOI: 10.1073/pnas.0507718102  0.64
2005 Meloni AR, Lai CH, Yao TP, Nevins JR. A mechanism of COOH-terminal binding protein-mediated repression. Molecular Cancer Research : McR. 3: 575-83. PMID 16254191 DOI: 10.1158/1541-7786.MCR-05-0088  0.64
2005 Black EP, Hallstrom T, Dressman HK, West M, Nevins JR. Distinctions in the specificity of E2F function revealed by gene expression signatures. Proceedings of the National Academy of Sciences of the United States of America. 102: 15948-53. PMID 16249342 DOI: 10.1073/pnas.0504300102  0.64
2005 Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK, Dobra A, Dressman HK, Bigner DD, Nevins JR, West M. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Research. 65: 4051-8. PMID 15899794 DOI: 10.1158/0008-5472.CAN-04-3936  0.64
2005 Berchuck A, Iversen ES, Lancaster JM, Pittman J, Luo J, Lee P, Murphy S, Dressman HK, Febbo PG, West M, Nevins JR, Marks JR. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3686-96. PMID 15897565 DOI: 10.1158/1078-0432.CCR-04-2398  0.64
2005 Zhu W, Giangrande PH, Nevins JR. Temporal control of cell cycle gene expression mediated by E2F transcription factors. Cell Cycle (Georgetown, Tex.). 4: 633-6. PMID 15876877  0.64
2005 Delong M, Yao G, Wang Q, Dobra A, Black EP, Chang JT, Bild A, West M, Nevins JR, Dressman H. DIG--a system for gene annotation and functional discovery. Bioinformatics (Oxford, England). 21: 2957-9. PMID 15870167 DOI: 10.1093/bioinformatics/bti467  0.64
2004 Giangrande PH, Zhu W, Schlisio S, Sun X, Mori S, Gaubatz S, Nevins JR. A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription. Genes & Development. 18: 2941-51. PMID 15574595 DOI: 10.1101/gad.1239304  0.64
2004 Zhu W, Giangrande PH, Nevins JR. E2Fs link the control of G1/S and G2/M transcription. The Embo Journal. 23: 4615-26. PMID 15510213 DOI: 10.1038/sj.emboj.7600459  0.64
2004 Huang ES, Nevins JR, West M, Kuo PC. An overview of genomic data analysis. Surgery. 136: 497-9. PMID 15349091 DOI: 10.1016/j.surg.2004.05.037  0.64
2004 Seo D, Wang T, Dressman H, Herderick EE, Iversen ES, Dong C, Vata K, Milano CA, Rigat F, Pittman J, Nevins JR, West M, Goldschmidt-Clermont PJ. Gene expression phenotypes of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 1922-7. PMID 15297278 DOI: 10.1161/01.ATV.0000141358.65242.1f  0.64
2004 Pittman J, Huang E, Dressman H, Horng CF, Cheng SH, Tsou MH, Chen CM, Bild A, Iversen ES, Huang AT, Nevins JR, West M. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proceedings of the National Academy of Sciences of the United States of America. 101: 8431-6. PMID 15152076 DOI: 10.1073/pnas.0401736101  0.64
2004 Berchuck A, Iversen ES, Lancaster JM, Dressman HK, West M, Nevins JR, Marks JR. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. American Journal of Obstetrics and Gynecology. 190: 910-25. PMID 15118612 DOI: 10.1016/j.ajog.2004.02.005  0.64
2004 Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, Sears R. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nature Cell Biology. 6: 308-18. PMID 15048125 DOI: 10.1038/ncb1110  0.64
2004 Giangrande PH, Zhu W, Rempel RE, Laakso N, Nevins JR. Combinatorial gene control involving E2F and E Box family members. The Embo Journal. 23: 1336-47. PMID 15014447 DOI: 10.1038/sj.emboj.7600134  0.64
2004 Lancaster JM, Dressman HK, Whitaker RS, Havrilesky L, Gray J, Marks JR, Nevins JR, Berchuck A. Gene expression patterns that characterize advanced stage serous ovarian cancers. Journal of the Society For Gynecologic Investigation. 11: 51-9. PMID 14706684 DOI: 10.1016/j.jsgi.2003.07.004  0.64
2004 Cook JG, Chasse DA, Nevins JR. The regulated association of Cdt1 with minichromosome maintenance proteins and Cdc6 in mammalian cells. The Journal of Biological Chemistry. 279: 9625-33. PMID 14672932 DOI: 10.1074/jbc.M311933200  0.64
2004 Dobra A, Hans C, Jones B, Nevins JR, Yao G, West M. Sparse graphical models for exploring gene expression data Journal of Multivariate Analysis. 90: 196-212. DOI: 10.1016/j.jmva.2004.02.009  0.64
2003 Huang ES, Black EP, Dressman H, West M, Nevins JR. Gene expression phenotypes of oncogenic signaling pathways. Cell Cycle (Georgetown, Tex.). 2: 415-7. PMID 12963829  0.64
2003 Nevins JR, Huang ES, Dressman H, Pittman J, Huang AT, West M. Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Human Molecular Genetics. 12: R153-7. PMID 12928487 DOI: 10.1093/hmg/ddg287  0.64
2003 Black EP, Huang E, Dressman H, Rempel R, Laakso N, Asa SL, Ishida S, West M, Nevins JR. Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Research. 63: 3716-23. PMID 12839964  0.4
2003 Huang E, West M, Nevins JR. Gene expression profiling for prediction of clinical characteristics of breast cancer. Recent Progress in Hormone Research. 58: 55-73. PMID 12795414 DOI: 10.1210/rp.58.1.55  0.64
2003 Huang E, Ishida S, Pittman J, Dressman H, Bild A, Kloos M, D'Amico M, Pestell RG, West M, Nevins JR. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nature Genetics. 34: 226-30. PMID 12754511 DOI: 10.1038/ng1167  0.64
2003 Giangrande PH, Hallstrom TC, Tunyaplin C, Calame K, Nevins JR. Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. Molecular and Cellular Biology. 23: 3707-20. PMID 12748276 DOI: 10.1128/MCB.23.11.3707-3720.2003  0.64
2003 Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM, West M, Nevins JR, Huang AT. Gene expression predictors of breast cancer outcomes. Lancet (London, England). 361: 1590-6. PMID 12747878 DOI: 10.1016/S0140-6736(03)13308-9  0.64
2002 Martell RE, Nevins JR, Sullenger BA. Optimizing aptamer activity for gene therapy applications using expression cassette SELEX. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 30-4. PMID 12095300 DOI: 10.1006/mthe.2002.0624  0.64
2002 Cook JG, Park CH, Burke TW, Leone G, DeGregori J, Engel A, Nevins JR. Analysis of Cdc6 function in the assembly of mammalian prereplication complexes. Proceedings of the National Academy of Sciences of the United States of America. 99: 1347-52. PMID 11805305 DOI: 10.1073/pnas.032677499  0.64
2002 Sears RC, Nevins JR. Signaling networks that link cell proliferation and cell fate. The Journal of Biological Chemistry. 277: 11617-20. PMID 11805123 DOI: 10.1074/jbc.R100063200  0.64
2002 Kegel KB, Meloni AR, Yi Y, Kim YJ, Doyle E, Cuiffo BG, Sapp E, Wang Y, Qin ZH, Chen JD, Nevins JR, Aronin N, DiFiglia M. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. The Journal of Biological Chemistry. 277: 7466-76. PMID 11739372 DOI: 10.1074/jbc.M103946200  0.64
2001 Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G. The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 414: 457-62. PMID 11719808 DOI: 10.1038/35106593  0.64
2001 West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA, Marks JR, Nevins JR. Predicting the clinical status of human breast cancer by using gene expression profiles. Proceedings of the National Academy of Sciences of the United States of America. 98: 11462-7. PMID 11562467 DOI: 10.1073/pnas.201162998  0.64
2001 Leone G, Sears R, Huang E, Rempel R, Nuckolls F, Park CH, Giangrande P, Wu L, Saavedra HI, Field SJ, Thompson MA, Yang H, Fujiwara Y, Greenberg ME, Orkin S, ... ... Nevins JR, et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Molecular Cell. 8: 105-13. PMID 11511364 DOI: 10.1016/S1097-2765(01)00275-1  0.64
2001 Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M, Nevins JR. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Molecular and Cellular Biology. 21: 4684-99. PMID 11416145 DOI: 10.1128/MCB.21.14.4684-4699.2001  0.64
2001 Burke TW, Cook JG, Asano M, Nevins JR. Replication Factors MCM2 and ORC1 Interact with the Histone Acetyltransferase HBO1 Journal of Biological Chemistry. 276: 15397-15408. PMID 11278932 DOI: 10.1074/jbc.M011556200  0.64
2000 Gaubatz S, Lindeman GJ, Ishida S, Jakoi L, Nevins JR, Livingston DM, Rempel RE. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control Molecular Cell. 6: 729-735. PMID 11030352  0.64
2000 Rempel RE, Saenz-Robles MT, Storms R, Morham S, Ishida S, Engel A, Jakoi L, Melhem MF, Pipas JM, Smith C, Nevins JR. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages Molecular Cell. 6: 293-306. PMID 10983977 DOI: 10.1016/S1097-2765(00)00030-7  0.64
1999 Meloni AR, Smith EJ, Nevins JR. A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor. Proceedings of the National Academy of Sciences of the United States of America. 96: 9574-9. PMID 10449734 DOI: 10.1073/pnas.96.17.9574  0.64
1999 Leone G, DeGregori J, Jakoi L, Cook JG, Nevins JR. Collaborative role of E2F transcriptional activity and G1 cyclin- dependent kinase activity in the induction of S phase Proceedings of the National Academy of Sciences of the United States of America. 96: 6626-6631. PMID 10359762 DOI: 10.1073/pnas.96.12.6626  0.64
1999 Sears R, Leone G, DeGregori J, Nevins JR. Ras enhances Myc protein stability Molecular Cell. 3: 169-179. PMID 10078200 DOI: 10.1016/S1097-2765(00)80308-1  0.64
1998 Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS, Nevins JR. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase Genes and Development. 12: 2120-2130. PMID 9679057  0.64
1998 Yan Z, Degregori J, Shohet R, Leone G, Stillman B, Nevins JR, Williams RS. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells Proceedings of the National Academy of Sciences of the United States of America. 95: 3603-3608. PMID 9520412 DOI: 10.1073/pnas.95.7.3603  0.64
1997 Nevins JR, Leone G, DeGregori J, Jakoi L. Role of the Rb/E2F pathway in cell growth control Journal of Cellular Physiology. 173: 233-236. PMID 9365528 DOI: 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F  0.64
1997 Nevins JR, Degregori J, Jakoi L, Leone G. Functional analysis of E2F transcription factor Methods in Enzymology. 283: 205-219. PMID 9251021 DOI: 10.1016/S0076-6879(97)83017-0  0.64
1997 Degregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis Proceedings of the National Academy of Sciences of the United States of America. 94: 7245-7250. PMID 9207076 DOI: 10.1073/pnas.94.14.7245  0.64
1997 Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F Nature. 387: 422-426. PMID 9163430 DOI: 10.1038/387422a0  0.64
1996 Ohtani K, DeGregori J, Leone G, Herendeen DR, Kelly TJ, Nevins JR. Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Molecular and Cellular Biology. 16: 6977-84. PMID 8943353  0.64
1996 Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR. The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state Molecular and Cellular Biology. 16: 6965-6976. PMID 8943352 DOI: 10.1128/MCB.16.12.6965  0.64
1996 Asano M, Nevins JR, Wharton RP. Ectopic E2F expression induces S phase and apoptosis in Drosophila imaginal discs. Genes & Development. 10: 1422-32. PMID 8647438  0.64
1996 Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, Howley PM. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proceedings of the National Academy of Sciences of the United States of America. 93: 4350-4. PMID 8633069  0.64
1996 Cress WD, Nevins JR. A role for a bent DNA structure in E2F-mediated transcription activation. Molecular and Cellular Biology. 16: 2119-27. PMID 8628278 DOI: 10.1128/MCB.16.5.2119  0.64
1996 Cress WD, Nevins JR. Use of the E2F transcription factor by DNA tumor virus regulatory proteins. Current Topics in Microbiology and Immunology. 208: 63-78. PMID 8575213 DOI: 10.1007/978-3-642-79910-5_3  0.64
1995 Ohtani K, Degregori J, Nevins JR. Regulation of the cyclin E gene by transcription factor E2F1 Proceedings of the National Academy of Sciences of the United States of America. 92: 12146-12150. PMID 8618861 DOI: 10.1073/pnas.92.26.12146  0.64
1995 Kowalik TF, DeGregori J, Schwarz JK, Nevins JR. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis Journal of Virology. 69: 2491-2500. PMID 7884898  0.64
1995 Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S, Wang XF, Nevins JR. Expression of the E2F1 transcription factor overcomes type β transforming growth factor-mediated growth suppression Proceedings of the National Academy of Sciences of the United States of America. 92: 483-487. PMID 7831315 DOI: 10.1073/pnas.92.2.483  0.64
1995 Smith EJ, Nevins JR. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2 Molecular and Cellular Biology. 15: 338-344. PMID 7799940 DOI: 10.1128/MCB.15.1.338  0.64
1995 DeGregori J, Kowalik T, Nevins JR. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes Molecular and Cellular Biology. 15: 4215-4224. PMID 7623816  0.64
1995 DeGregori J, Leone G, Ohtani K, Miron A, Nevins JR. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity Genes and Development. 9: 2783-2887. PMID 7498785 DOI: 10.1101/gad.9.23.2873  0.64
1994 Cress WD, Nevins JR. Interacting domains of E2F1, DP1, and the adenovirus E4 protein. Journal of Virology. 68: 4213-9. PMID 8207796 DOI: 10.1128/jvi.68.7.4213-4219.1994  0.64
1994 Kraus VB, Inostroza JA, Yeung K, Reinberg D, Nevins JR. Interaction of the Dr1 inhibitory factor with the TATA binding protein is disrupted by adenovirus E1A Proceedings of the National Academy of Sciences of the United States of America. 91: 6279-6282. PMID 8022773 DOI: 10.1073/pnas.91.14.6279  0.64
1994 Johnson DG, Cress WD, Jakoi L, Nevins JR. Oncogenic capacity of the E2F1 gene. Proceedings of the National Academy of Sciences of the United States of America. 91: 12823-7. PMID 7809128 DOI: 10.1073/pnas.91.26.12823  0.64
1993 Schwarz JK, Devoto SH, Smith EJ, Chellappan SP, Jakoi L, Nevins JR. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. The Embo Journal. 12: 1013-20. PMID 8458319  0.64
1993 Cress WD, Johnson DG, Nevins JR. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Molecular and Cellular Biology. 13: 6314-25. PMID 8413230 DOI: 10.1128/MCB.13.10.6314  0.64
1992 Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F Genes and Development. 6: 177-185. PMID 1531329  0.64
1992 Kraus VB, Moran E, Nevins JR. Promoter-Specific trans-Activation by the Adenovirus E1A12S Product Involves Separate E1A Domains Molecular and Cellular Biology. 12: 4391-4399. PMID 1406628  0.64
1992 Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, Nevins JR. Adeno virus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product Proceedings of the National Academy of Sciences of the United States of America. 89: 4549-4553. PMID 1316611  0.64
1992 Devoto SH, Mudryj M, Pines J, Hunter T, Nevins JR. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell. 68: 167-76. PMID 1310073 DOI: 10.1016/0092-8674(92)90215-X  0.32
1991 Gilmartin GM, Nevins JR. Molecular analyses of two poly(A) site-processing factors that determine the recognition and efficiency of cleavage of the pre-mRNA. Molecular and Cellular Biology. 11: 2432-8. PMID 2017162  0.64
1991 Nevins JR, Chellappan SP, Mudryj M, Hiebert S, Devoto S, Horowitz J, Hunter T, Pines J. E2F transcription factor is a target for the RB protein and the cyclin A protein Cold Spring Harbor Symposia On Quantitative Biology. 56: 157-162. PMID 1840249 DOI: 10.1101/SQB.1991.056.01.020  0.64
1991 Raychaudhuri P, Bagchi S, Devoto SH, Kraus VB, Moran E, Nevins JR. Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes Genes and Development. 5: 1200-1211. PMID 1829698  0.64
1991 Mudryj M, Devoto SH, Hiebert SW, Hunter T, Pines J, Nevins JR. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A Cell. 65: 1243-1253. PMID 1829647 DOI: 10.1016/0092-8674(91)90019-U  0.64
1991 Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein Cell. 65: 1053-1061. PMID 1828392 DOI: 10.1016/0092-8674(91)90557-F  0.64
1991 Hiebert SW, Blake M, Azizkhan J, Nevins JR. Role of E2F transcription factor in E1A-mediated trans activation of cellular genes Journal of Virology. 65: 3547-3552. PMID 1828272  0.64
1991 Weigel RJ, Devoto SH, Nevins JR. Adenovirus 12S E1A gene represses differentiation of F9 teratocarcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 87: 9878-82. PMID 1702220 DOI: 10.1073/pnas.87.24.9878  0.44
1991 Ahmed YF, Gilmartin GM, Hanly SM, Nevins JR, Greene WC. The HTLV-I Rex response element mediates a novel form of mRNA polyadenylation. Cell. 64: 727-37. PMID 1671761  0.64
1991 Weiss EA, Gilmartin GM, Nevins JR. Poly(A) site efficiency reflects the stability of complex formation involving the downstream element. The Embo Journal. 10: 215-9. PMID 1671216  0.64
1990 Rooney RJ, Raychaudhuri P, Nevins JR. E4F and ATF, two transcription factors that recognize the same site, can be distinguished both physically and functionally: A role for E4F in E1A trans activation Molecular and Cellular Biology. 10: 5138-5149. PMID 2169022 DOI: 10.1128/MCB.10.10.5138  0.64
1990 Bagchi S, Raychaudhuri P, Nevins JR. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: A novel mechanism for E1A trans-activation Cell. 62: 659-669. PMID 2143697 DOI: 10.1016/0092-8674(90)90112-R  0.64
1990 Chellappan SP, Nevins JR. DNA octamer element can confer E1A trans-activation, and adenovirus infection results in a stimulation of the DNA-binding activity of OTF-1/NFIII factor Proceedings of the National Academy of Sciences of the United States of America. 87: 5878-5882. PMID 2143023 DOI: 10.1073/pnas.87.15.5878  0.64
1990 Mudryj M, Hiebert SW, Nevins JR. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway Embo Journal. 9: 2179-2184. PMID 2141565  0.64
1990 Raychaudhuri P, Bagchi S, Neill SD, Nevins JR. Activation of the E2F transcription factor in adenovirus-infected cells involves E1A-dependent stimulation of DNA-binding activity and induction of cooperative binding mediated by an E4 gene product Journal of Virology. 64: 2702-2710. PMID 2139893 DOI: 10.1128/jvi.64.6.2702-2710.1990  0.64
1990 Simon MC, Rooney RJ, Fisch TM, Heintz N, Nevins JR. E1A-dependent trans-activation of the c-fos promoter requires the TATAA sequence. Proceedings of the National Academy of Sciences of the United States of America. 87: 513-7. PMID 2137244 DOI: 10.1073/pnas.87.2.513  0.64
1989 Gilmartin GM, Nevins JR. An ordered pathway of assembly of components required for polyadenylation site recognition and processing. Genes & Development. 3: 2180-90. PMID 2628166  0.64
1989 Raychaudhuri P, Bagchi S, Nevins JR. DNA-binding activity of the adenovirus-induced E4F transcription factor is regulated by phosphorylation Genes &Amp; Development. 3: 620-627. PMID 2545525 DOI: 10.1101/gad.3.5.620  0.64
1989 Young KS, Weigel R, Hiebert S, Nevins JR. Adenovirus E1A-mediated negative control of genes activated during F9 differentiation Molecular and Cellular Biology. 9: 3109-3113. PMID 2528683 DOI: 10.1128/MCB.9.7.3109  0.64
1989 Bagchi S, Raychaudhuri P, Nevins JR. Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system Proceedings of the National Academy of Sciences of the United States of America. 86: 4352-4356. PMID 2525256 DOI: 10.1073/pnas.86.12.4352  0.64
1989 Hiebert SW, Lipp M, Nevins JR. E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor Proceedings of the National Academy of Sciences of the United States of America. 86: 3594-3598. PMID 2524830  0.64
1989 Yee AS, Raychaudhuri P, Jakoi L, Nevins JR. The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding. Molecular and Cellular Biology. 9: 578-85. PMID 2523514 DOI: 10.1128/MCB.9.2.578  0.64
1988 McDevitt MA, Gilmartin GM, Reeves WH, Nevins JR. Multiple factors are required for poly(A) addition to a mRNA 3' end. Genes & Development. 2: 588-97. PMID 3384332  0.64
1988 Galli G, Guise J, Tucker PW, Nevins JR. Poly(A) site choice rather than splice site choice governs the regulated production of IgM heavy-chain RNAs Proceedings of the National Academy of Sciences of the United States of America. 85: 2439-2443. PMID 3128787 DOI: 10.1073/pnas.85.8.2439  0.64
1988 Nevins JR, Raychaudhuri P, Yee AS, Rooney RJ, Kovesdi I, Reichel R. Transactivation by the adenovirus E1A gene. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 66: 578-83. PMID 3048331 DOI: 10.1139/o88-068  0.64
1988 Lazaridis I, Babich A, Nevins JR. Role of the adenovirus 72-kDa DNA binding protein in the rapid decay of early viral mRNA Virology. 165: 438-445. PMID 2970153 DOI: 10.1016/0042-6822(88)90587-9  0.64
1988 Gilmartin GM, McDevitt MA, Nevins JR. Multiple factors are required for specific RNA cleavage at a poly(A) addition site. Genes & Development. 2: 578-87. PMID 2838381  0.64
1988 Simon MC, Fisch TM, Benecke BJ, Nevins JR, Heintz N. Definition of multiple, functionally distinct TATA elements, one of which is a target in the hsp70 promoter for E1A regulation. Cell. 52: 723-9. PMID 2830991 DOI: 10.1016/0092-8674(88)90410-2  0.64
1987 Galli G, Guise JW, McDevitt MA, Tucker PW, Nevins JR. Relative position and strengths of poly(A) sites as well as transcription termination are critical to membrane versus secreted mu-chain expression during B-cell development Genes & Development. 1: 471-481. PMID 3119424 DOI: 10.1101/gad.1.5.471  0.64
1987 Simon MC, Kitchener K, Kao HT, Hickey E, Weber L, Voellmy R, Heintz N, Nevins JR. Selective induction of human heat shock gene transcription by the adenovirus E1A gene products, including the 12S E1A product. Molecular and Cellular Biology. 7: 2884-90. PMID 2959854 DOI: 10.1128/MCB.7.8.2884  0.64
1985 Kao HT, Capasso O, Heintz N, Nevins JR. Cell cycle control of the human HSP70 gene: implications for the role of a cellular E1A-like function. Molecular and Cellular Biology. 5: 628-33. PMID 3872994 DOI: 10.1128/MCB.5.4.628  0.64
1985 Imperiale MJ, Hart RP, Nevins JR. An enhancer-like element in the adenovirus E2 promoter contains sequences essential for uninduced and E1A-induced transcription Proceedings of the National Academy of Sciences of the United States of America. 82: 381-385. PMID 3855557 DOI: 10.1073/pnas.82.2.381  0.64
1985 Hart RP, McDevitt MA, Ali H, Nevins JR. Definition of essential sequences and functional equivalence of elements downstream of the adenovirus E2A and the early simian virus 40 polyadenylation sites Molecular and Cellular Biology. 5: 2975-2983. PMID 3018490 DOI: 10.1128/MCB.5.11.2975  0.64
1985 Hart RP, McDevitt MA, Nevins JR. Poly(A) site cleavage in a HeLa nuclear extract is dependent on downstream sequences Cell. 43: 677-683. PMID 2866847 DOI: 10.1016/0092-8674(85)90240-5  0.64
1983 Babich A, Feldman LT, Nevins JR, Darnell JE, Weinberger C. Effect of adenovirus on metabolism of specific host mRNAs: transport control and specific translational discrimination. Molecular and Cellular Biology. 3: 1212-21. PMID 6688459 DOI: 10.1128/MCB.3.7.1212  0.64
1981 Nevins JR, Wilson MC. Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing. Nature. 290: 113-8. PMID 7207591 DOI: 10.1038/290113a0  0.64
1981 Babich A, Nevins JR. The stability of early adenovirus mRNA is controlled by the viral 72 kd DNA-binding protein Cell. 26: 371-379. PMID 6895718 DOI: 10.1016/0092-8674(81)90206-3  0.64
1980 Babich A, Nevins JR, Darnell JE. Early capping of transcripts from the adenovirus major late transcription unit. Nature. 287: 246-8. PMID 7432461 DOI: 10.1038/287246a0  0.64
1980 Nevins JR, Blanchard JM, Darnell JE. Transcription units of adenovirus type 2. Termination of transcription beyond the poly(A) addition site in early regions 2 and 4. Journal of Molecular Biology. 144: 377-86. PMID 7253021 DOI: 10.1016/0022-2836(80)90096-0  0.64
1980 Darnell JE, Ziff E, Nevins JR, Wilson M. Variety in the mechanisms of adenovirus gene control. Annals of the New York Academy of Sciences. 354: 466-71. PMID 6939405 DOI: 10.1111/j.1749-6632.1980.tb27985.x  0.64
1980 Wilson MC, Nevins JR, Blanchard JM, Ginsberg HS, Darnell JE. Metabolism of mRNA from the transforming region of adenovirus 2. Cold Spring Harbor Symposia On Quantitative Biology. 44: 447-55. PMID 6933041 DOI: 10.1101/SQB.1980.044.01.048  0.64
1979 Nevins JR, Ginsberg HS, Blanchard JM, Wilson MC, Darnell JE. Regulation of the primary expression of the early adenovirus transcription units. Journal of Virology. 32: 727-33. PMID 513202 DOI: 10.1128/jvi.32.3.727-733.1979  0.64
1979 Fraser NW, Nevins JR, Ziff E, Darnell JE. The major late adenovirus type-2 transcription unit: termination is downstream from the last poly(A) site. Journal of Molecular Biology. 129: 643-56. PMID 480353 DOI: 10.1016/0022-2836(79)90474-1  0.64
Show low-probability matches.